<SEC-DOCUMENT>0001157523-18-002457.txt : 20181119
<SEC-HEADER>0001157523-18-002457.hdr.sgml : 20181119
<ACCEPTANCE-DATETIME>20181119160324
ACCESSION NUMBER:		0001157523-18-002457
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20181119
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181119
DATE AS OF CHANGE:		20181119

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		181192518

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a51901846.htm
<DESCRIPTION>HOLOGIC, INC. 8-K
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2018 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 10pt">
    <hr style="height: 4.0 pt; width: 100%; color: #000000; text-align: center">
    <hr style="height: 1.0 pt; width: 100%; color: #000000; text-align: center">


    <p style="text-align: center">
      <br>
      <font style="font-size: 14pt; font-family: Times New Roman"><b>UNITED
      STATES</b></font><b><font style="font-size: 14pt; font-family: Times New Roman"><br style="font-family: Times New Roman; font-size: 14pt"></font><font style="font-size: 14pt; font-family: Times New Roman">SECURITIES
      AND EXCHANGE COMMISSION</font></b><br><font style="font-size: 12pt; font-family: Times New Roman"><b>Washington,
      D.C. 20549</b></font><br><font style="font-family: Times New Roman"><b>______________</b></font><br><br><font style="font-size: 18pt; font-family: Times New Roman"><b>FORM
      8-K</b></font><br><font style="font-family: Times New Roman"><b>______________</b></font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>CURRENT
      REPORT</b></font><br><font style="font-size: 12pt; font-family: Times New Roman"><b>Pursuant
      to Section 13 or 15(d)</b></font><br><font style="font-size: 12pt; font-family: Times New Roman"><b>of
      the Securities Exchange Act of 1934</b></font>
    </p>
    <p style="text-align: center">
      <font style="font-size: 10pt; font-family: Times New Roman"><b>Date of
      Report (Date of earliest event reported): November 19, 2018</b></font><br><font style="font-family: Times New Roman"><b>______________</b></font><br>
    </p>
    <p style="text-align: center">
      <font style="font-size: 22pt; font-family: Times New Roman"><b>HOLOGIC,
      INC.</b></font><br><font style="font-size: 10pt; font-family: Times New Roman"><b>(Exact
      name of registrant as specified in its charter)</b></font><br><font style="font-family: Times New Roman"><b>______________</b></font><br><br>
    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt; width: 100%" cellspacing="0">
      <tr>
        <td valign="top" style="text-align: center; padding-left: 0.0px; width: 33%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Delaware</b>
          </p>
        </td>
        <td valign="bottom" style="text-align: center; white-space: nowrap; padding-left: 0.0px; padding-right: 0.0px; width: 34%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>1-36214</b>
          </p>
        </td>
        <td valign="bottom" style="text-align: center; white-space: nowrap; padding-left: 0.0px; padding-right: 0.0px; width: 33%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>04-2902449</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: center; padding-left: 0.0px; width: 33%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>(State or other jurisdiction</b>
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>of incorporation)</b>
          </p>
        </td>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 34%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>(Commission </b>
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>File Number)</b>
          </p>
        </td>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 33%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>(IRS Employer </b>
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Identification No.)</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt; width: 100%" cellspacing="0">
      <tr>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 50%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>250 Campus Drive, Marlborough, MA</b>
          </p>
        </td>
        <td valign="bottom" style="text-align: center; white-space: nowrap; padding-left: 0.0px; padding-right: 0.0px; width: 50%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>01752</b>
          </p>
        </td>
      </tr>
      <tr>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 50%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <font style="font-size: 10pt; font-family: Times New Roman"><b>(Address
            of principal executive offices)</b></font>
          </p>
        </td>
        <td valign="bottom" style="text-align: center; padding-left: 0.0px; width: 50%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <font style="font-size: 10pt; font-family: Times New Roman"><b>(Zip
            Code)</b></font>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: center">
      <b>(508) 263-2900</b><br><b>(Registrant&#8217;s telephone number, including
      area code) </b><br><br><b>(Former name or former address, if changed
      since last report)</b>
    </p>
    <p style="text-align: center">
      <font style="font-family: Times New Roman"><b>______________</b></font><br>
    </p>
    <p>

    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">Check the
      appropriate box below if the Form 8-K filing is intended to
      simultaneously satisfy the filing obligation of the registrant under any
      of the following provisions:</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Written
      communications pursuant to Rule 425 under the Securities Act (17 CFR
      230.425)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Soliciting
      material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
      240.14d-2(b))</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
      <font style="font-size: 10pt; font-family: Times New Roman">Pre-commencement
      communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
      240.13e-4(c))</font>
    </p>
    <p>

    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">Indicate by
      check mark whether the registrant is an emerging growth company as
      defined in Rule 405 of the Securities Act of 1933 (17 CFR&#160;&#167;230.405) or
      Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).</font>
    </p>
    <p>
      Emerging growth company <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
    </p>
    <p>
      <font style="font-size: 10pt; font-family: Times New Roman">If an
      emerging growth company, indicate by check mark if the registrant has
      elected not to use the extended transition period for complying with any
      new or revised financial accounting standards provided pursuant to
      Section 13(a) of the Exchange Act.</font> <font style="font-size: 10pt; font-family: Arial Unicode MS">&#8414;</font>
    </p>
    <hr style="text-align: center; color: #000000; height: 1.0 pt; width: 100%">
    <hr style="text-align: center; color: #000000; height: 4.0 pt; width: 100%">


    <p>

    </p>
    <div style="margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt; width: 100%" cellspacing="0">
      <tr>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 10%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Item 5.02</b>
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 90%">
          <p style="font-size: 10pt">
            <b>Departure of Directors or Certain Officers; Election of
            Directors; Appointment of Certain Officers; Compensatory
            Arrangements of Certain Officers.</b>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p style="text-align: justify; text-indent: 30.0px; font-size: 10pt">
      On November 19, 2018, the Board of Directors of Hologic, Inc. (the
      &#8220;Company&#8221;) appointed Ludwig N. Hantson as a director of the Company,
      effective November 21, 2018.&#160;&#160;Dr. Hantson is the Chief Executive Officer
      of Alexion Pharmaceuticals, Inc.&#160;&#160;
    </p>
    <p style="text-align: justify; text-indent: 30.0px; font-size: 10pt">
      Dr. Hantson, who will stand for election by stockholders at the
      Company&#8217;s 2019 Annual Meeting of Stockholders, has been appointed to
      serve on the Company&#8217;s Compensation Committee and its&#160;Nominating and
      Corporate Governance Committee.&#160;&#160;As a non-employee director of the
      Company, he will receive compensation as described in the &#8220;Director
      Compensation&#8221; section of the Company&#8217;s Proxy Statement.
    </p>
    <p style="text-align: justify; text-indent: 30.0px; font-size: 10pt">
      A copy of the Company&#8217;s press release announcing the election of Dr.
      Hantson is filed with this Current Report on Form 8-K as Exhibit 99.1.
    </p>
    <p>

    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt; width: 100%" cellspacing="0">
      <tr>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 10%">
          <b>Item 9.01</b>
        </td>
        <td valign="top" style="padding-left: 0.0px; width: 90%">
          <b>Financial Statements and Exhibits</b>
        </td>
      </tr>
    </table>
    </div>
    <p>
      (d) Exhibits
    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt; width: 100%" cellspacing="0">
      <tr>
        <td style="width: 9%">

        </td>
        <td style="width: 1%">
          &#160;
        </td>
        <td style="width: 90%">

        </td>
      </tr>
      <tr>
        <td valign="bottom" style="border-bottom-color: black; text-align: center; border-bottom-width: 1.0pt; padding-left: 0.0px; width: 9%; border-bottom-style: solid">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Exhibit</b>
          </p>
          <p style="margin-bottom: 0px; margin-top: 0px">
            <b>Number</b>
          </p>
        </td>
        <td valign="bottom" style="text-align: left; padding-bottom: 2.0px; padding-left: 0.0px; width: 1%">

        </td>
        <td valign="bottom" style="border-bottom-color: black; text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; width: 90%; border-bottom-style: solid">
          <b>Description</b>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: center; white-space: nowrap; padding-left: 0.0px; padding-right: 0.0px; width: 9%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <a href="a51901846ex99_1.htm">99.1</a>
          </p>
        </td>
        <td style="width: 1%">

        </td>
        <td valign="top" style="padding-left: 0.0px; width: 90%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            <a href="a51901846ex99_1.htm">Press Release dated November 19,
            2018.</a>
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
    <div style="margin-bottom: 10pt; margin-left: 0pt; text-indent: 0pt; margin-right: 0pt; width: 100%">
      <div>
        <div style="text-align: left">

        </div>
      </div>
      <div style="page-break-after: always">
        <div style="text-align: center">

        </div>
        <div style="text-align: center">
          <hr style="height: 1.5pt; color: black">

        </div>
      </div>
      <div>
        <div style="text-align: right">

        </div>
      </div>
    </div>
    <p>

    </p>
    <p style="text-align: center">
      <u><font style="font-size: 10pt; font-family: Times New Roman"><b>SIGNATURES</b></font></u>
    </p>
    <p style="text-indent: 30.0px; font-size: 10pt">
      <font style="font-size: 10pt; font-family: Times New Roman">Pursuant to
      the requirements of the Securities Exchange Act of 1934, the registrant
      has duly caused this report to be signed on its behalf by the
      undersigned hereunto duly authorized.</font>
    </p>
    <p style="text-indent: 30.0px; font-size: 10pt">

    </p>
<div style="text-align:left">
    <table style="margin-bottom: 10.0px; font-family: Times New Roman; font-size: 10pt; width: 100%" cellspacing="0">
      <tr>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 5%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Date:
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 45%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            November 19, 2018
          </p>
        </td>
        <td colspan="2" valign="top" style="text-align: left; padding-left: 0.0px">
          <p style="margin-bottom: 0px; margin-top: 0px">
            HOLOGIC, INC.
          </p>
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td colspan="2">
          &#160;
        </td>
      </tr>
      <tr>
        <td valign="top" style="text-align: left; padding-bottom: 2.0px; padding-left: 0.0px; width: 5%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-bottom: 2.0px; padding-left: 0.0px; width: 45%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            &#160;
          </p>
        </td>
        <td valign="top" style="text-align: left; padding-bottom: 2.0px; padding-left: 0.0px; width: 3%">
          By:
        </td>
        <td valign="top" style="border-bottom-color: black; text-align: left; border-bottom-width: 1.0pt; padding-left: 0.0px; width: 47%; border-bottom-style: solid">
          <p style="margin-bottom: 0px; margin-top: 0px">
            /s/ Patricia K. Dolan
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 3%">

        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 47%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Patricia K. Dolan
          </p>
        </td>
      </tr>
      <tr>
        <td style="width: 5%">

        </td>
        <td style="width: 45%">

        </td>
        <td style="width: 3%">

        </td>
        <td valign="top" style="text-align: left; padding-left: 0.0px; width: 47%">
          <p style="margin-bottom: 0px; margin-top: 0px">
            Vice President and Corporate Secretary
          </p>
        </td>
      </tr>
    </table>
    </div>
    <p>

    </p>
  </body>
</html>
<!--<!DOCTYPE html
     PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN"
     "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">-->
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a51901846ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
<!--Copyright 2018 Business Wire, a Berkshire Hathaway company.-->
<!--All rights reserved www.businesswire.com-->
  </head>
  <body style="font-family: Times New Roman; font-size: 8pt">
    <p style="text-align: right">
      <b>Exhibit 99.1</b>
    </p>
    <p style="text-align: center">
      <font style="font-size: 12pt; font-family: Times New Roman"><b>Ludwig N.
      Hantson</b></font><b><font style="font-size: 12pt; font-family: Times New Roman">
      </font><font style="font-size: 12pt; font-family: Times New Roman">Elected
      to Hologic Board of Directors</font></b>
    </p>
    <p>
      MARLBOROUGH, Mass.--(BUSINESS WIRE)--November 19, 2018--Hologic, Inc.
      (Nasdaq: HOLX) announced today that Ludwig N. Hantson has been elected
      to the Company&#8217;s Board of Directors, effective immediately.
    </p>
    <p>
      Dr. Hantson, who has more than 30 years of experience in the life
      sciences industry, is the Chief Executive Officer of Alexion
      Pharmaceuticals, Inc., a publicly-traded global biopharmaceutical
      company. Before joining Alexion, Dr.&#160;Hantson was President and Chief
      Executive Officer of Baxalta Incorporated. He led Baxalta&#8217;s spin-off as
      a public company from Baxter in July of 2015. He joined Baxter in May
      2010 as the President of Baxter BioScience, and previously held
      leadership roles with Novartis AG and Johnson &amp; Johnson.
    </p>
    <p>
      &#8220;It is a pleasure to welcome Ludwig to our Board,&#8221; said Steve MacMillan,
      Hologic&#8217;s Chairman, President and Chief Executive Officer. &#8220;With his
      experience leading innovative companies, he brings additional depth to
      the operational expertise, strategic vision and global perspective of
      our Board.&#8221;
    </p>
    <p>
      Dr. Hantson received his Ph.D. in motor rehabilitation and physical
      therapy, Master&#8217;s degree in physical education, and a certification in
      high secondary education, all from the University of Louvain in Belgium.
    </p>
    <p>
      <u><b>About Hologic</b></u>
    </p>
    <p>
      Hologic, Inc. is an innovative medical technology company primarily
      focused on improving women's health and well-being through early
      detection and treatment. For more information on Hologic, visit&#160;<u>www.hologic.com</u>.
    </p>
    <p>
      Hologic and associated logos are trademarks and/or registered trademarks
      of Hologic, Inc. and/or its subsidiaries in&#160;the United States&#160;and/or
      other countries.
    </p>
    <p>
      <u><b>Forward-Looking Statements</b></u>
    </p>
    <p>
      This news release contains forward-looking information that involves
      risks and uncertainties, including statements about the Company's plans,
      objectives, expectations and intentions, and statements regarding the
      Company's Board of Directors. These forward-looking statements are based
      on assumptions made by the Company as of this date and are subject to
      known and unknown risks and uncertainties that could cause actual
      results to differ materially from those anticipated. These risks
      include, but are not limited to, the risk that the Company may not be
      able to attract and retain qualified Board members or executives. These
      risks are not exhaustive. Other factors that could adversely affect the
      Company's business and prospects are described in the filings made by
      the Company with the SEC. The Company expressly disclaims any obligation
      or undertaking to release publicly any updates or revisions to any such
      statements presented here to reflect any change in expectations or any
      change in events, conditions or circumstances on which any such
      statements are based.
    </p>
    <p>
      SOURCE: Hologic, Inc.
    </p>
    <p>
      CONTACT:<br>Hologic, Inc.<br>Michael Watts<br>Vice President, Investor
      Relations and Corporate Communications<br>(858) 410-8588
    </p>
  </body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
